<!DOCTYPE html>
<html lang="en">

<head>
    <meta charset="UTF-8">
    <meta name="viewport" content="width=device-width, initial-scale=1.0">
    <title>Lesson 4.1: The Mechanisms of Chronic Low-Grade Systemic Inflammation</title>
    <style>
        /* Base & Reset */
        * {
            box-sizing: border-box;
        }

        body {
            font-family: Georgia, 'Times New Roman', serif;
            line-height: 1.8;
            color: #2d2d2d;
            background: #f8f6f3;
            margin: 0;
            padding: 0;
        }

        /* Main Container */
        .lesson-container {
            max-width: 860px;
            margin: 0 auto;
            padding: 40px 30px;
            background: #ffffff;
            min-height: 100vh;
            box-shadow: 0 0 60px rgba(0, 0, 0, 0.08);
        }

        /* Brand Header */
        .brand-header {
            text-align: center;
            padding-bottom: 30px;
            margin-bottom: 35px;
            border-bottom: 1px solid #eee;
        }

        .brand-logo {
            max-width: 220px;
            height: auto;
            margin-bottom: 5px;
        }

        /* Module Header - BLUE/PURPLE theme for Immune Modulation */
        .module-header {
            background: linear-gradient(135deg, #1e3a8a 0%, #3b82f6 100%);
            padding: 35px 35px 30px;
            border-radius: 16px;
            margin-bottom: 30px;
            position: relative;
            overflow: hidden;
        }

        .module-header::after {
            content: '';
            position: absolute;
            bottom: 0;
            left: 0;
            width: 100%;
            height: 4px;
            background: linear-gradient(90deg, #B8860B, #D4A84B, #B8860B);
        }

        .module-label {
            margin: 0;
            font-size: 11px;
            color: rgba(255, 255, 255, 0.75);
            text-transform: uppercase;
            letter-spacing: 2.5px;
            font-weight: 500;
        }

        .lesson-title {
            margin: 10px 0 0 0;
            font-size: 28px;
            color: #ffffff;
            font-weight: 700;
            line-height: 1.3;
            position: relative;
        }

        .lesson-meta {
            display: flex;
            gap: 12px;
            margin-top: 20px;
            padding-top: 18px;
            border-top: 1px solid rgba(255, 255, 255, 0.15);
            flex-wrap: wrap;
        }

        .meta-item {
            display: flex;
            align-items: center;
            gap: 6px;
            font-size: 12px;
            color: rgba(255, 255, 255, 0.85);
            background: rgba(255, 255, 255, 0.1);
            padding: 5px 12px;
            border-radius: 4px;
        }

        /* Table of Contents */
        .toc-box {
            background: linear-gradient(135deg, #fafafa 0%, #f5f5f5 100%);
            border-radius: 14px;
            padding: 24px 28px;
            margin-bottom: 35px;
            border: 1px solid #e8e8e8;
        }

        .toc-box .box-label {
            font-weight: 600;
            color: #1e3a8a;
            margin: 0 0 18px 0;
            font-size: 12px;
            text-transform: uppercase;
            letter-spacing: 2px;
            padding-bottom: 12px;
            border-bottom: 1px solid #e0e0e0;
        }

        .toc-list {
            list-style: none;
            margin: 0;
            padding: 0;
            display: grid;
            grid-template-columns: repeat(2, 1fr);
            gap: 8px 24px;
        }

        .toc-list a {
            display: flex;
            align-items: center;
            padding: 8px 12px;
            color: #555;
            text-decoration: none;
            font-size: 14px;
            border-radius: 6px;
            transition: all 0.2s ease;
        }

        .toc-list a:hover {
            background: white;
            color: #3b82f6;
            box-shadow: 0 2px 8px rgba(0, 0, 0, 0.06);
        }

        .toc-list .section-num {
            display: inline-flex;
            align-items: center;
            justify-content: center;
            width: 26px;
            height: 26px;
            background: #1e3a8a;
            color: white;
            font-weight: 600;
            font-size: 11px;
            border-radius: 6px;
            margin-right: 12px;
            flex-shrink: 0;
        }

        /* Learning Objectives */
        .objectives-box {
            background: #eff6ff;
            border: 2px solid #3b82f6;
            border-radius: 14px;
            padding: 30px 35px;
            margin-bottom: 40px;
        }

        .objectives-box .box-label {
            font-weight: 600;
            color: #1e3a8a;
            margin: 0 0 18px 0;
            font-size: 13px;
            text-transform: uppercase;
            letter-spacing: 2px;
            display: flex;
            align-items: center;
            gap: 10px;
        }

        .objectives-box .box-label::before {
            content: 'ðŸŽ¯';
            font-size: 18px;
        }

        .objectives-box ul {
            margin: 0;
            padding-left: 22px;
        }

        .objectives-box li {
            margin-bottom: 14px;
            font-size: 16px;
            line-height: 1.7;
        }

        /* Key Terms Box */
        .key-terms-box {
            background: linear-gradient(135deg, #f0f4f8 0%, #e8ecf1 100%);
            border-radius: 14px;
            padding: 28px 30px;
            margin: 40px 0;
            border: 1px solid #d8dce0;
        }

        .key-terms-box .box-label {
            font-weight: 600;
            color: #1e3a8a;
            margin: 0 0 18px 0;
            font-size: 13px;
            text-transform: uppercase;
            letter-spacing: 2px;
        }

        .terms-grid {
            display: grid;
            grid-template-columns: repeat(auto-fit, minmax(280px, 1fr));
            gap: 16px;
        }

        .term-item {
            background: white;
            padding: 16px 18px;
            border-radius: 10px;
            border-left: 4px solid #3b82f6;
        }

        .term-item .term {
            font-weight: 700;
            color: #1e3a8a;
            font-size: 15px;
            margin: 0 0 6px 0;
        }

        .term-item .definition {
            font-size: 14px;
            color: #555;
            margin: 0;
            line-height: 1.6;
        }

        /* Section Headings */
        h2 {
            font-size: 24px;
            color: #1e3a8a;
            margin: 50px 0 20px 0;
            font-weight: 600;
            position: relative;
            padding-bottom: 12px;
        }

        h2::after {
            content: '';
            position: absolute;
            bottom: 0;
            left: 0;
            width: 60px;
            height: 3px;
            background: #B8860B;
        }

        /* Paragraphs & Highlights */
        p {
            font-size: 17px;
            margin-bottom: 20px;
            color: #333;
        }

        .highlight {
            background: linear-gradient(180deg, transparent 60%, #e0e7ff 60%);
            padding: 0 4px;
            font-weight: 500;
            color: #1e3a8a;
        }

        .stat-highlight {
            color: #1e3a8a;
            font-weight: 700;
        }

        /* Welcome Box */
        .welcome-box {
            background: linear-gradient(135deg, #eff6ff 0%, #dbeafe 100%);
            padding: 30px 35px;
            border-radius: 14px;
            margin-bottom: 40px;
            border: 1px solid #bfdbfe;
        }

        .welcome-box h3 {
            margin: 0 0 15px 0;
            font-size: 20px;
            color: #1e3a8a;
            font-weight: 600;
        }

        /* Statistics Box */
        .stats-box {
            background: linear-gradient(135deg, #1e3a8a 0%, #3b82f6 100%);
            padding: 40px;
            border-radius: 16px;
            margin: 35px 0;
            position: relative;
            overflow: hidden;
        }

        .stats-grid {
            display: grid;
            grid-template-columns: repeat(auto-fit, minmax(140px, 1fr));
            gap: 25px;
            position: relative;
        }

        .stat-item {
            text-align: center;
        }

        .stat-number {
            font-size: 38px;
            font-weight: 700;
            color: white;
            line-height: 1;
            margin-bottom: 8px;
        }

        .stat-label {
            font-size: 12px;
            color: rgba(255, 255, 255, 0.85);
            text-transform: uppercase;
            letter-spacing: 1px;
        }

        /* Case Study */
        .case-study {
            background: #f8f9fb;
            border-radius: 16px;
            margin: 40px 0;
            overflow: hidden;
            box-shadow: 0 4px 20px rgba(0, 0, 0, 0.06);
        }

        .case-study-header {
            background: linear-gradient(135deg, #1e3a8a 0%, #3b82f6 100%);
            padding: 20px 30px;
            color: white;
        }

        .case-study-content {
            padding: 28px 30px;
        }

        /* Comparison Table */
        .data-table-container {
            overflow-x: auto;
            margin: 30px 0;
        }

        table {
            width: 100%;
            border-collapse: collapse;
            background: white;
            border-radius: 10px;
            overflow: hidden;
            border: 1px solid #e5e7eb;
        }

        th {
            background: #1e3a8a;
            color: white;
            padding: 15px;
            text-align: left;
            font-size: 14px;
            text-transform: uppercase;
        }

        td {
            padding: 15px;
            border-bottom: 1px solid #f3f4f6;
            font-size: 15px;
            color: #4b5563;
        }

        tr:last-child td {
            border-bottom: none;
        }

        /* Check Understanding */
        .check-understanding {
            background: #fdfbf7;
            border: 2px solid #B8860B;
            border-radius: 16px;
            padding: 32px;
            margin: 45px 0;
        }

        .reveal-btn {
            background: #1e3a8a;
            color: white;
            border: none;
            padding: 10px 20px;
            border-radius: 8px;
            cursor: pointer;
            margin-top: 10px;
        }

        .answer-text {
            display: none;
            padding: 15px;
            background: #f0f4f8;
            border-radius: 8px;
            margin-top: 10px;
        }

        /* Takeaways & References */
        .takeaways-box {
            background: #f3f4f6;
            padding: 25px;
            border-radius: 12px;
            margin-top: 40px;
        }

        .references-box {
            margin-top: 40px;
            padding: 25px;
            border-top: 1px solid #eee;
            font-size: 14px;
            color: #666;
        }

        .references-box h4 {
            color: #1e3a8a;
            margin-bottom: 15px;
        }

        .lesson-footer {
            text-align: center;
            padding: 40px 0;
            border-top: 1px solid #eee;
            margin-top: 40px;
        }

        @media (max-width: 768px) {
            .toc-list { grid-template-columns: 1fr; }
            .stats-grid { grid-template-columns: 1fr 1fr; }
        }
    </style>
</head>

<body>
    <div class="lesson-container">
        <div class="brand-header">
            <img src="/logoimg/LOGO_ACCREDI.png" alt="AccrediPro Academy" class="brand-logo">
        </div>

        <header class="module-header">
            <p class="module-label">Module 4: Inflammaging & Immune Modulation</p>
            <h1 class="lesson-title">Lesson 4.1: The Mechanisms of Chronic Low-Grade Systemic Inflammation</h1>
            <div class="lesson-meta">
                <span class="meta-item">35 min read</span>
                <span class="meta-item">Lesson 1 of 10</span>
                <span class="meta-item">V.I.T.A.L.S. Methodâ„¢: I</span>
            </div>
        </header>

        <div class="toc-box">
            <p class="box-label">In This Lesson</p>
            <ul class="toc-list">
                <li><a href="#intro"><span class="section-num">1</span>Defining Inflammaging</a></li>
                <li><a href="#acute-chronic"><span class="section-num">2</span>Acute vs. Chronic Inflammation</a></li>
                <li><a href="#drivers"><span class="section-num">3</span>Molecular Drivers: NF-ÎºB & NLRP3</a></li>
                <li><a href="#sasp"><span class="section-num">4</span>The SASP and Cellular Senescence</a></li>
                <li><a href="#biomarkers"><span class="section-num">5</span>Clinical Biomarkers & Testing</a></li>
                <li><a href="#vital-connection"><span class="section-num">6</span>The V.I.T.A.L.S. Integration</a></li>
            </ul>
        </div>

        <div class="objectives-box">
            <p class="box-label">Learning Objectives</p>
            <ul>
                <li>Define "Inflammaging" and explain its role as a primary driver of biological aging.</li>
                <li>Differentiate between beneficial acute inflammation and deleterious chronic low-grade systemic inflammation (LGSI).</li>
                <li>Identify the key molecular pathways, including NF-ÎºB and the NLRP3 inflammasome, that sustain chronic inflammation.</li>
                <li>Explain how the Senescence-Associated Secretory Phenotype (SASP) spreads inflammation to healthy tissues.</li>
                <li>Interpret clinical biomarkers like hs-CRP and IL-6 to assess a client's inflammatory burden.</li>
            </ul>
        </div>

        <div class="welcome-box">
            <h3>The Silent Fire Within</h3>
            <p>Welcome to Module 4. We are now entering the "I" of the V.I.T.A.L.S. Methodâ„¢: <span class="highlight">Inflammaging & Immune Modulation</span>. While previous modules focused on energy and structure, we now address the chemical environment in which our cells reside. Chronic inflammation is not just a symptom of aging; it is a fundamental cause. By mastering these mechanisms, you will be able to help clients extinguish the "silent fire" that accelerates DNA damage, mitochondrial decay, and cognitive decline.</p>
        </div>

        <div class="key-terms-box">
            <p class="box-label">ðŸ”¬ Key Terms to Know</p>
            <div class="terms-grid">
                <div class="term-item">
                    <p class="term">Inflammaging</p>
                    <p class="definition">A term coined by Claudio Franceschi describing the age-related increase in the levels of pro-inflammatory markers in blood and tissues.</p>
                </div>
                <div class="term-item">
                    <p class="term">SASP</p>
                    <p class="definition">Senescence-Associated Secretory Phenotype; the cocktail of pro-inflammatory cytokines secreted by "zombie" cells.</p>
                </div>
                <div class="term-item">
                    <p class="term">hs-CRP</p>
                    <p class="definition">High-sensitivity C-Reactive Protein; a blood marker produced by the liver in response to systemic inflammation.</p>
                </div>
                <div class="term-item">
                    <p class="term">Cytokine Storm</p>
                    <p class="definition">An overproduction of immune cells and their activating compounds (cytokines), leading to tissue damage.</p>
                </div>
            </div>
        </div>

        <h2 id="intro">1. Defining Inflammaging: The Core Driver of Aging</h2>
        <p>In the year 2000, Professor Claudio Franceschi introduced a concept that would revolutionize longevity science: <span class="highlight">Inflammaging</span>. This phenomenon is defined as a chronic, sterile (non-infectious), low-grade, and systemic inflammatory state that progressively increases with chronological age.</p>

        <p>Unlike the redness and swelling of a bee sting, inflammaging is <span class="highlight">subclinical</span>. A client may feel "fine" while their IL-6 levels are 3x higher than optimal, silently eroding their arterial walls and neural connections. A 2021 study involving over 3,000 participants found that individuals with the highest inflammatory scores had a <span class="stat-highlight">42% higher risk of all-cause mortality</span> over a 10-year period (Sayed et al., 2021).</p>

        <div class="stats-box">
            <div class="stats-grid">
                <div class="stat-item">
                    <div class="stat-number">2-4x</div>
                    <div class="stat-label">Increase in Cytokines with Age</div>
                </div>
                <div class="stat-item">
                    <div class="stat-number">42%</div>
                    <div class="stat-label">Higher Mortality Risk</div>
                </div>
                <div class="stat-item">
                    <div class="stat-number">0.5 mg/L</div>
                    <div class="stat-label">Optimal hs-CRP Level</div>
                </div>
                <div class="stat-item">
                    <div class="stat-number">70%</div>
                    <div class="stat-label">Linked to Chronic Disease</div>
                </div>
            </div>
        </div>

        <h2 id="acute-chronic">2. Acute vs. Chronic Inflammation: The Survival Paradox</h2>
        <p>Inflammation is not inherently "bad." It is a vital survival mechanism. Without acute inflammation, a simple cut could be fatal. However, aging causes this mechanism to become "stuck" in the ON position. We must distinguish between the two to provide accurate guidance to clients.</p>

        <div class="data-table-container">
            <table>
                <thead>
                    <tr>
                        <th>Feature</th>
                        <th>Acute Inflammation</th>
                        <th>Inflammaging (Chronic LGSI)</th>
                    </tr>
                </thead>
                <tbody>
                    <tr>
                        <td><strong>Trigger</strong></td>
                        <td>Pathogens, Tissue Injury</td>
                        <td>Cellular Debris, SASP, Gut Dysbiosis</td>
                    </tr>
                    <tr>
                        <td><strong>Duration</strong></td>
                        <td>Days to Weeks</td>
                        <td>Months to Decades</td>
                    </tr>
                    <tr>
                        <td><strong>Outcome</strong></td>
                        <td>Healing & Repair</td>
                        <td>Tissue Degradation & Fibrosis</td>
                    </tr>
                    <tr>
                        <td><strong>Symptoms</strong></td>
                        <td>Pain, Redness, Swelling</td>
                        <td>Fatigue, Cognitive Blur, Joint Stiffness</td>
                    </tr>
                    <tr>
                        <td><strong>Scope</strong></td>
                        <td>Localized</td>
                        <td>Systemic (Whole Body)</td>
                    </tr>
                </tbody>
            </table>
        </div>

        <h2 id="drivers">3. Molecular Drivers: The NF-ÎºB and NLRP3 Pathways</h2>
        <p>To modulate inflammation, we must understand the "master switches." The most critical is <span class="highlight">NF-ÎºB (Nuclear Factor kappa-light-chain-enhancer of activated B cells)</span>. Think of NF-ÎºB as a general that receives signals of stress and orders the production of inflammatory "soldiers" (cytokines like TNF-Î± and IL-1Î²).</p>

        <p>In younger individuals, NF-ÎºB is tightly regulated. In aging, however, persistent oxidative stress and DNA damage keep NF-ÎºB constitutively active. This leads to a feedback loop where inflammation causes more oxidative stress, which in turn activates more NF-ÎºB.</p>

        <p>Alongside NF-ÎºB is the <span class="highlight">NLRP3 Inflammasome</span>. This is a multi-protein complex that acts as a sensor for "danger signals" within the cell, such as uric acid crystals or escaped mitochondrial DNA. When triggered, the NLRP3 inflammasome activates Caspase-1, which matures pro-inflammatory cytokines into their active, destructive forms.</p>

        <h2 id="sasp">4. The SASP and Cellular Senescence</h2>
        <p>One of the primary drivers of inflammaging is the accumulation of <span class="highlight">senescent cells</span> (dealt with in the "S" pillar of V.I.T.A.L.S.). These "zombie cells" stop dividing but refuse to die. Instead, they develop a <span class="highlight">Senescence-Associated Secretory Phenotype (SASP)</span>.</p>

        <p>The SASP is a toxic brew of cytokines, chemokines, and proteases. A single senescent cell can "infect" its neighbors by secreting these factors, turning a healthy tissue environment into an inflammatory one. This is why senolytic interventions are so potentâ€”they don't just kill a cell; they remove a local source of systemic fire.</p>

        <div class="case-study">
            <div class="case-study-header">
                <div class="box-label">CASE STUDY: The "Healthy" Executive</div>
                <div class="subtitle">Inflammaging hidden behind a normal BMI</div>
            </div>
            <div class="case-study-content">
                <p><strong>Client:</strong> Robert, 54, CEO. Reports "brain fog," afternoon fatigue, and lingering soreness after light workouts. BMI is 24.5 (Normal).</p>
                <p><strong>Assessment:</strong> Robertâ€™s standard blood work was "normal," but a Longevity Panel revealed:</p>
                <ul>
                    <li><strong>hs-CRP:</strong> 3.8 mg/L (High risk is >3.0)</li>
                    <li><strong>IL-6:</strong> 4.2 pg/mL (Elevated)</li>
                    <li><strong>Fasting Insulin:</strong> 14 uIU/mL (Suggesting meta-inflammation)</li>
                </ul>
                <p><strong>Intervention:</strong> Robert began a protocol focusing on the "I" pillar: High-dose Omega-3s (EPA/DHA), Curcumin phytosome, and time-restricted feeding to dampen NF-ÎºB activity.</p>
                <p><strong>Outcome:</strong> After 12 weeks, hs-CRP dropped to 0.9 mg/L. Robert reported a "lifting of the veil" regarding his brain fog and a 40% improvement in recovery time.</p>
            </div>
        </div>

        <h2 id="biomarkers">5. Clinical Biomarkers: Measuring the Invisible Fire</h2>
        <p>As an Anti-Aging Coach, you must move beyond "normal" ranges. Conventional medicine often considers an hs-CRP of 2.9 mg/L as "normal," but for longevity, we target <span class="highlight">below 1.0 mg/L</span>.</p>

        <p>A meta-analysis of 54 prospective studies (n=160,309) demonstrated that <span class="stat-highlight">C-reactive protein levels are as predictive of cardiovascular disease as cholesterol levels</span> (Emerging Risk Factors Collaboration, 2010). Key markers to monitor include:</p>
        <ul>
            <li><strong>hs-CRP:</strong> The "gold standard" for systemic inflammation.</li>
            <li><strong>Interleukin-6 (IL-6):</strong> A primary cytokine that drives the liver to produce CRP. Elevated IL-6 is a strong predictor of physical frailty in the elderly.</li>
            <li><strong>TNF-Î±:</strong> Linked to insulin resistance and muscle wasting (sarcopenia).</li>
            <li><strong>Fibrinogen:</strong> Reflects both inflammation and clotting risk.</li>
        </ul>

        <h2 id="vital-connection">6. Integration with the V.I.T.A.L.S. Methodâ„¢</h2>
        <p>Inflammaging does not exist in a vacuum. It interacts with every other pillar of the V.I.T.A.L.S. Methodâ„¢:</p>
        <ul>
            <li><strong>V (Vascular):</strong> Inflammation oxidizes LDL cholesterol, leading to plaque formation.</li>
            <li><strong>T (Telomeres):</strong> Chronic inflammation accelerates telomere shortening by increasing cellular turnover and oxidative stress.</li>
            <li><strong>A (Autophagy):</strong> High levels of inflammation can inhibit autophagy, preventing the cell from cleaning up the very debris that triggers inflammation.</li>
            <li><strong>S (Senescence):</strong> As discussed, the SASP is a primary source of the inflammatory load.</li>
        </ul>

        <div class="check-understanding">
            <p class="box-label">Check Your Understanding</p>
            <div class="question-item">
                <p class="question-text">How does "Inflammaging" differ from the inflammation you might experience after a sprained ankle?</p>
                <button class="reveal-btn" onclick="this.nextElementSibling.classList.toggle('show')">Reveal Answer</button>
                <div class="answer-text">Inflammaging is "sterile" (no infection), low-grade (subclinical), systemic (whole body), and chronic (persistent), whereas a sprained ankle involves acute, localized, high-grade inflammation that resolves once healing is complete.</div>
            </div>
            <div class="question-item">
                <p class="question-text">What is the "master switch" protein complex that triggers the production of pro-inflammatory cytokines in response to cellular stress?</p>
                <button class="reveal-btn" onclick="this.nextElementSibling.classList.toggle('show')">Reveal Answer</button>
                <div class="answer-text">NF-ÎºB (Nuclear Factor kappa-light-chain-enhancer of activated B cells) is the primary transcription factor responsible for upregulating inflammatory genes.</div>
            </div>
        </div>

        <div class="takeaways-box">
            <p class="box-label">Key Takeaways</p>
            <ul>
                <li>Inflammaging is a subclinical, systemic fire that drives nearly all age-related diseases.</li>
                <li>The SASP (secreted by senescent cells) allows inflammation to spread like a contagion through tissues.</li>
                <li>Optimal longevity targets for hs-CRP are <1.0 mg/L, significantly lower than conventional "normal" ranges.</li>
                <li>Inflammation acts as a bridge between all pillars of the V.I.T.A.L.S. Methodâ„¢, particularly DNA integrity and senescence.</li>
            </ul>
        </div>

        <div class="references-box">
            <h4>References & Further Reading</h4>
            <ol>
                <li>Franceschi, C. et al. (2000). "Inflamm-aging: An Evolutionary Perspective on Immunosenescence." Annals of the New York Academy of Sciences.</li>
                <li>Sayed, N. et al. (2021). "An inflammatory aging clock (iAge) based on deep learning tracks multimorbidity and immune senescence." Nature Aging.</li>
                <li>Emerging Risk Factors Collaboration. (2010). "C-reactive protein concentration and risk of coronary heart disease, stroke, and mortality: an individual participant meta-analysis." The Lancet.</li>
                <li>Furman, D. et al. (2019). "Chronic inflammation in the etiology of disease across the life span." Nature Medicine.</li>
                <li>Ferrucci, L. & Fabbri, E. (2018). "Inflammageing: chronic inflammation in ageing, cardiovascular disease, and frailty." Nature Reviews Cardiology.</li>
                <li>Lopez-Otin, C. et al. (2023). "Hallmarks of aging: An expanding universe." Cell.</li>
            </ol>
        </div>

        <footer class="lesson-footer">
            <img src="/logoimg/LOGO_ACCREDI.png" alt="AccrediPro Academy" class="footer-logo">
            <p class="brand">AccrediPro Academy: Anti-Aging & Longevity Certification</p>
            <p class="copyright">&copy; 2024 AccrediPro. All rights reserved. Professional Use Only.</p>
        </footer>
    </div>
</body>

</html>